FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Sunday, June 3, 2018
FDA wants to shorten new drug monopolies to cut costs
FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Related Posts:
Dollar starts 2018 in doldrums, European stocks groggy- California rolls its own recreational pot sales out for 2018
- Euro zone factory growth surges to record; more uneven in Asia
- BP sees U.S. earnings boost from tax change; will take $1.5b one-off charge
- Not-so-happy new year for UK commuters as fares rise
0 comments:
Post a Comment